Introduction
Breast cancer (BC) is the leading cause of cancer deaths among females worldwide, with an estimated .500,000 deaths occurring in 2012. 1 As the incidence of BC is increasing rapidly, 2 understanding the biological mechanisms involved and exploring novel targets are urgently needed.
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liu et al inflammatory mediators such as cytokines, chemokines, nitric oxide synthase, and boost immune cell proliferation and migration. [7] [8] [9] However, AIF1L is majorly expressed in the epithelial cells, such as renal glomerulus and renal tubules, endometrial gland, mammary ductal epithelial cells, glandular epithelium of epididymis, and vascular endothelial cells of spleen. 10, 11 Although AIF1 and AIF1L have remarkable sequence homology and structural similarity, they show a distinct pattern of tissue specific expression, so we speculated they have different biological functions.
AIF1L co-localizes with and crosslinks filamentous actin (F-actin) with subcortical filaments and localizes to membrane ruffle-like cellular projections and adhesion structures in a Shigella invasion model. 5 AIF1L deficiency, which was functionally analyzed by siRNA silencing, was shown to result in significant loss and rearrangement of F-actin stress fibers, as shown by phalloidin staining, and led to cytoskeletal injury in immortalized human podocytes. 12 So far, the potential roles of AIF1L in carcinogenesis have not been well characterized.
We studied AIF1L expression levels in BC, the effects of AIF1L on migration and invasion of BC cells, and characterized an AIF1L-related signaling pathway that influences cytoskeletal modifications.
Patients and methods cell culture and engineering
The MDA-MB-231 BC cell line was purchased from American Type Culture Collection. Cells were cultured in L15 medium (Hyclone) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific, MA USA). Adenoviruses purchased from Hanbio Biotechnology Co., Ltd. (Shanghai, People's Republic of China) were used to overexpress human AIF1L in MDA-MB-231 cells via transient transfection.
Microarray and immunohistochemistry
A total of 287 tissue samples from primary BC patients who underwent curative resection were collected at the First Hospital of China Medical University between December 2003 and April 2007. Tissue specimens were initially paraffin embedded and processed for routine histological evaluation. Written informed consent was obtained from each patient. Clinicopathologic data, including age, gender, World Health Organization histological type, and TNM stage, as well as estrogen receptor (ER), progesterone receptor (PR), Ki67, and human epidermal growth factor receptor 2 (HER2) expression, were collected. A total of 259 BC patients with at least a 5-year follow-up were included in prognosis analysis. This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of China Medical University. All samples were evaluated by two experienced pathologists to confirm diagnosis. AIF1L expression levels were detected using a two-step immunohistochemical method (Beijing Zhongshan Golden Bridge Biotechnology Company, Beijing, People's Republic of China). Rabbit polyclonal antibodies against human AIF1L were purchased from Abcam (Shanghai, People's Republic of China). Tissue microarray slides were deparaffinized in xylene and hydrated with graded alcohol before incubation with 3% H 2 O 2 and heat-induced antigen retrieval. Slides were incubated with primary antibodies overnight at 4°C and stained using a two-step detection system; counterstaining was performed with hematoxylin. All procedures were carried out according to the manufacturers' instructions. For negative controls, sections were treated with 0.01 mol/L PBS instead of primary antibodies.
Cells expressing AIF1L proteins had visible brown granules in the cytoplasm and membrane. Immunostaining intensities were evaluated by two independent pathologists in a blinded manner. The scoring system was based on the intensity and extent of staining. Expression levels were classified as low and high, as previously described. 13 
Biological informatics analysis for aiF1l expression and methylation
The Cancer Genome Atlas (TCGA) RNA-sequencing database (level 3 data) included 1,100 BC samples and 112 normal controls. To identify an association between AIF1L methylation and expression, we also downloaded HumanMethylation450 data (level 3 data) for breast tumor tissues and adjacent non-tumor tissues from TCGA. The association between AIF1L mRNA expression and DNA methylation was determined by calculating the Spearman correlation coefficient. The total number of matched samples was 868. Beta-value statistics were used to measure methylation levels.
14 AIF1L protein expression in BC was confirmed according to The Human Protein Atlas. 50 cancer cell line encyclopedia (ccle) data analysis
The CCLE project is an effort to conduct detailed genetic characterization of a large panel of human cancer cell lines. CCLE provides public access analysis and visualization of DNA copy number, mRNA expression, mutation data, and more for ~1,000 cancer cell lines, 15, 16 including 52 BC cells that were analyzed in the present study. We withdrew AIF1L co-expression genes from the CCLE database with R language, then used DAVID Bioinformatics Resources 6.7 17, 18 Data from the BC cell lines were also evaluated using gene set enrichment analysis (GSEA) and GSEA2-2.2.3 software. AIF1L expression levels were dichotomized into two groups to annotate phenotype with msigdb.v5.2.symbols gene sets. 19, 20 All other parameters were set to default values. 21, 22 Transwell migration and invasion assays Migration and invasion assays were performed as previously described. 23 For the invasion assays, 50 µL Matrigel (Corning, NY, USA) was added to the well inserts and incubated overnight. Cells (5×10 4 ) were suspended in serum-free culture media and seeded into Transwell inserts. Plates on the bottom received complete media and were incubated at 37°C for 24 hours. Unmigrated cells were removed using cotton swabs. Cells were fixed with 4% paraformaldehyde and stained with a 1% crystal violet solution (Sigma-Aldrich St. Louis, MO, USA). For each plate, five random fields were counted at 10× magnification. Images were processed with ImageJ software to count the number of cells in the migration and invasion assay.
Protein extraction and immunoblots
Cells were solubilized in radioimmunoprecipitation assay lysis buffer with protease inhibitors. Equal amounts of protein were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes. Membranes were blocked with 5% nonfat milk for 2 hours and incubated overnight at 4°C with primary antibodies. Proteins were detected using an enhanced chemiluminescence kit and photographed using the ChemiDoc MP System (Bio-Rad Laboratories Inc., Hercules, CA, USA). Rabbit monoclonal antibodies against human FAK and RHOA were purchased from Abcam.
cell spreading assays A cell spreading assay was performed as previously described. 24 MDA-MB-231 controls and AIF1L-overexpressing cells were resuspended in serum-free medium. A total of 5×10 4 cells were added to Matrigel-coated glass coverslips. Sixty minutes after plating, cells were fixed with 4% paraformaldehyde for 20 minutes at room temperature. After washing with PBS, 0.1% Triton X-100 (in PBS) was added for 10 minutes at room temperature. Cells were blocked with 10% normal goat serum for 10 minutes at room temperature. Cells were incubated with 0.5 µM tetramethylrhodamine-phalloidin (SigmaAldrich) for 1 hour at room temperature and counterstained with 4′,6-diamidino-2-phenylindole to visualize nuclei. Coverslips were imaged using epifluorescence microscopy (Nikon Corporation, Tokyo Japan). Images were processed with ImageJ software to measure the areas of the cell and nucleus. Circularity and aspect ratio were used to measure cell shape as previously described. 25, 26 Both cell circularity and aspect ratio were used to measure the roundness of a cell. Over 50 cells were quantified per sample. The experiment was performed in three technical replicates.
statistical analysis
Statistical analysis was performed with SPSS 17.0 (SPSS Inc., Chicago, IL, USA) or R language. Continuous data are shown as the mean ± SD or standard error of mean for normally distributed data. Chi-squared test or Fisher's exact test was used to compare different groups. Log-rank testing was used to assess the associations between disease-free survival and disease covariates to identify prognostic factors. Two sided P,0.05 was considered statistically significant.
Results
Downregulation of aiF1l expression in Bc
In this cohort, positive rates of AIF1L protein expression in BC (28.6%, 82/287) were significantly lower than in tumoradjacent tissues (58.3%, 28/48; P=0.007; Figure 1A and B). AIF1L mRNA expression was also significantly decreased in BC compared with controls in TCGA ( Figure 1E ). Methylation of gene CpG island promoters is a generally accepted mechanism for silencing expression. Strong associations between methylation patterns and expression have been reported. 27 HumanMethylation450 BeadChip (450 K) is based on the Illumina Technology and contains 482,421 probes, targeting 99% of genes and 96% of CpG island regions. 28 Spearman correlation coefficients were calculated, which showed a negative correlation between the expression and methylation of AIF1L genes ( Figure 1G) . Notably, AIF1L genes were hypermethylated in tumor samples compared to normal controls ( Figure 1F ). Using data from Protein Atlas, AIF1L protein staining against HPA020522 and HPA056852 antibodies (rabbit polyclonal antibody; Sigma-Aldrich) was visible in both the cytoplasm and membranes. Normal breast glandular cells showed higher staining intensity for HPA020522 and medium staining intensity for HPA056852. + were significantly higher than HER2 − (P=0.038). AIF1L expression was lower in triple-negative breast cancer (TNBC) compared with non-TNBC. No significant differences in AIF1L levels were detected in relation to age, T&N stage subtype, ER and PR status, and Ki67 status (Table 1) .
low expression of aiF1l correlates with shorter disease-free survival in Bc patients
Patients with low AIF1L expression showed a poor diseasefree survival rate (P=0.040; Figure 1 
Potential biological functions of aiF1l
To explore the unique roles of AIF1L, we identified 196 AIF1L co-expression genes from the CCLE database with R language by setting the Pearson coefficient .0.6. After performing gene ontology and the Kyoto Encyclopedia of Genes and Genomes pathway analysis using DAVID tools, 17 the most enriched biological themes were related to tight junctions and cell junctions (Figure 2A ). To further assess the biological function of AIF1L in breast tumorigenesis, we applied GSEA to BC cells from the CCLE. Top 50 differentially expressed genes between low vs high expressions of AIF1L are shown in Table S1 . Downregulation of AIF1L was significantly correlated with focal adhesion (FA; Figure 2B ). Genes in the FA pathway were identified by GSEA ( Figure 2C ; Table S2 ).
aiF1l inhibits migration and invasion of MDa-MB-231 Bc cells
The mRNA expression levels of BC cells in CCLE are shown Figure S1 . AIF1L expression of MDA-MB-231 cells was lower than that of immortalized epithelial HMEL cells. To further investigate the effect of AIF1L overexpression on cell migration and invasion, the Transwell migration and invasion assays were performed. Transwell migration and invasion assays showed that transient overexpression of AIF1L significantly suppressed migration and invasion compared to the control group (P,0.05; Figure 3 ).
aiF1l inhibits MDa-MB-231 cell spreading and mediates focal adhesion kinase (FaK) levels involved in rOcK signaling
Cell migration and spreading are initiated by global reorganization of the actin cytoskeleton and extending actin polymerization-driven lamellipodium protrusions of the cell membrane. 29, 30 Thirty minutes after plating, cells overexpressing AIF1L spread less efficiently than the control cells ( Figure 4A , B, E) and were less elongated, as indicated by an increase in circularity and decrease in aspect ratio ( Figure 4C-F) . Elongated cells showed actin remodeling toward the membrane, which is equivalent to the formation of ruffles and pseudopodia ( Figure 4D ). FAK is a nonreceptor tyrosine kinase that plays a central role in cell migration through regulation of lamellipodial formation and FAs. 31, 32 Increased FAK expression has been correlated with increased clinical progression in BC.
33,34 Therefore, we assessed FAK expression in AIF1L-overexpressing MDA-MB-231 cells and controls and showed that AIF1L led to increased inhibition of FAK expression ( Figure 4G ). FAK is involved with activators and/or inhibitors of the small GTPase RhoA that enable FAK activity to be connected to alterations in polymerization of actin filaments during tumor cell adhesion and motility. 35, 36 RhoA expression was also inhibited by AIF1L overexpresssion in MDA-MB-231 cells ( Figure 4G ).
Discussion
In the present study, we analyzed the expression and clinicopathologic significance of AIF1L in BC. Low AIF1L protein expression was observed in 71.4% of BC samples in this cohort. AIF1L mRNA expression was also lower in patients with BC in TCGA cohort. Furthermore, AIF1L protein expression in BC was confirmed from Protein Atlas. Thus, AIF1L expression is downregulated in BC. Furthermore, we integrated AIF1L DNA methylation and gene expression from TCGA database and found that AIF1L downregulation may be due to hypermethylation of the promoter. Given that the Spearman correlation coefficient was very low, particularly with tumor tissues, we searched 51 and found that no genetic alterations in AIF1L were reported in 977 sequenced patients from TCGA. We hypothesized that in addition to methylation, there might be some other reason for AIF1L downregulation, such as a posttranscriptional regulation mechanism rather than gene mutation. Low AIF1L expression was detected in TNBC and was correlated with a poor postoperative disease-specific survival. TNBC accounts for ~15%-20% of BCs and is defined by the absence of ERα, PR, and HER2 amplification, which is resistant to conventional chemotherapy, lack of targeting agents and is often associated with a poor prognosis. 37, 38 AIF1L could be a unique molecular target of TNBCs.
CCLE data analysis revealed AIF1L-related pathways, including cell junction, tight junction, and FA. Of the AIF1L co-expression genes, CDH1 (cadherin 1, E-cadherin) is a major component of intercellular junctions, and loss of its expression has been shown to reduce BC invasion and metastasis. 39, 40 FAs connect the cytoskeleton and extracellular matrix (ECM). Interplay between the actin cytoskeleton and FA dynamics results in a balance between adhesion and contraction, which greatly influences cell migration. 35, 41 Although AIF1L induces cytoskeletal rearrangements in HeLa cells and podocytes, whether it is involved in BC progression, especially in TNBCs, is not understood. The data reported herein show that ectopic AIF1L expression suppresses MDA-MB-231 BC cell motility and invasion 
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aiF1l downregulation may predict a poor prognosis by inducing cytoskeletal modifications, which are achieved through FAK/RHOA signaling. High FAK expression was correlated with shorter overall survival and progression-free survival in patients with BC, especially in TNBC patients with high FAK expression. 42, 43 RhoA protein is also overexpressed in BC. 44, 45 The actin cytoskeleton is linked to invasive and metastatic phenotypes of malignant cancer cells. Cell migration is driven by cycles of actin polymerization and is initiated by cell membrane protrusions called filopodia, lamellipodia, and invadopodia. 46 These protrusions are stabilized by adhesions linking the actin cytoskeleton to ECM proteins and actomyosin contraction. 35, 47 Located on the inner face of the cell membrane, FAs form a vital link between the ECM and the cytoskeleton. Interplay between F-actin contractile forces and FA dynamics greatly influences cell migration capacity. 35 Integrin receptor binding to ECM proteins is one of the strongest activators of FAK. 48, 49 In the present study, MDA-MB-231 cells transfected with AIF1L showed decreased cell spreading, more circular cell shape, and formation of fewer protrusions. GSEA also found low AIF1L expression correlated with high expression of collagens such as COL4, COL6, COL5, and COL1. AIF1L may inhibit FAK/RHOA expression through interfering in cell-ECM signaling. But the accurate molecular mechanism needs further research. These results support a role for AIF1L in regulating actin remodeling associated with cell migration.
Conclusion
This study evaluated AIF1L expression in BC and found that AIF1L downregulation may predict a poor prognosis. AIF1L suppresses BC migration and invasion through regulating actin remodeling, which is dependent on FAK/RHOA signaling. However, additional mechanisms that influence AIF1L regulation of the actin cytoskeleton should be identified and characterized in the future.
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